ClinicalTrials.govpublic full text
Study of Pomalidomide Combined With Modified DA-EPOCH and Rituximab in KSHV-Associated Lymphomas
large cell lymphoma arising in kshv-associated multicentric castleman disease, primary effusion lymphoma, hhv8, pel, immune modulation, cc-4047, imid, interventional, phase1, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 896197
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.